The latest news from Mexican pharma, including Bayer’s big bet on oncology and Novartis’ aggressive expansion strategy as well as updates on the country’s vaccination drive, including the upcoming rollout of the J&J jab, why the country’s doctors are being denied vaccines, and the progression of trials for the Sanofi and Walvax shots.


Bayer targets cancer drugs in Mexico (El Universal)

The German pharmaceutical company Bayer will bet on the launch of anticancer drugs in the Mexican market.

The company aims for 30% of its revenues in the country to come from anticancer drugs by 2030, a similar percentage to that now provided by treatments for cardiovascular diseases.


Novartis expects “aggressive” growth in Mexico this year (Forbes)

The pharmaceutical company Novartis expects “aggressive” growth in the Mexican market during 2021. To achieve this, it proposes to reimagine current medicine.

“We plan a 7% growth in Mexico, it is very aggressive. It has to do with the conditions and opportunities that we see in the country,” declared Fernando Cruz, president of the company in Mexico, during his participation in the 2021 Forbes + Health Forum.


Flexibility at work is essential at Bayer Mexico (Expansion)

This time of the COVID-19 pandemic has been quite challenging for companies, which is why they have created various schemes to continue operating, but without neglecting aspects such as the physical and emotional health of employees. Bayer Mexico has adapted to this situation by being more flexible in the way of working.


Mexico’s doctors protest as vaccines denied to frontline health workers (The Guardian)

Doctors’ pleas receive little sympathy from government as critics say President Amlo favoring teachers – for political reasons.


Mexico to receive first J&J COVID-19 vaccines on Tuesday (Reuters)

Mexican health officials said on Monday the country will receive its first shipment of Johnson & Johnson(JNJ.N) COVID-19 vaccines the following day.

Mexico’s health regulator authorized the vaccine’s use last month and President Andres Manuel Lopez Obrador said the United States would donate 1 million J&J shots.


Mexico Ships First Locally Made Astra Shots to Latin America (Bloomberg Law)

Mexico shipped more than a million AstraZeneca Plc vaccines to Argentina, Belize, Bolivia and Paraguay over the weekend in the first batch of locally-produced shots.

Mexico sent 811,000 shots to Argentina, while Bolivia and Paraguay received 150,000 each and Belize 100,000, the Foreign Ministry tweeted on Saturday.


Mexico ramping up COVID-19 trial work tapping Sanofi, China’s shots in late-stage tests (Fierce Biotech)

French Big Pharma Sanofi, using its traditional vaccine approach, and Chinese biotech Walvax, using mRNA technology, are both set to start phase 3 trials in Mexico.

Sanofi, which has a deal with GlaxoSmithKline and uses a recombinant protein-based technology, is set to kick-start its late-stage effort soon after Mexico’s health regulator Cofepris gave it the all-clear this week, according to Reuters.